Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Lilian Chan 1 Article
Genetics of Parkinson’s Disease - A Clinical Perspective
Sang-Myung Cheon, Lilian Chan, Daniel Kam Yin Chan, Jae Woo Kim
J Mov Disord. 2012;5(2):33-41.
DOI: https://doi.org/10.14802/jmd.12009
  • 27,014 View
  • 100 Download
  • 13 Crossref
AbstractAbstract PDF

Discovering genes following Medelian inheritance, such as autosomal dominant-synuclein and leucine-rich repeat kinase 2 gene, or autosomal recessive Parkin, P-TEN-induced putative kinase 1 gene and Daisuke-Junko 1 gene, has provided great insights into the pathogenesis of Parkinson’s disease (PD). Genes found to be associated with PD through investigating genetic polymorphisms or via the whole genome association studies suggest that such genes could also contribute to an increased risk of PD in the general population. Some environmental factors have been found to be associated with genetic factors in at-risk patients, further implicating the role of gene-environment interactions in sporadic PD. There may be confusion for clinicians facing rapid progresses of genetic understanding in PD. After a brief review of PD genetics, we will discuss the insight of new genetic discoveries to clinicians, the implications of ethnic differences in PD genetics and the role of genetic testing for general clinicians managing PD patients.

Citations

Citations to this article as recorded by  
  • Exploring the complexities of 1C metabolism: implications in aging and neurodegenerative diseases
    Ayman Bou Ghanem, Yaman Hussayni, Raghid Kadbey, Yara Ratel, Shereen Yehya, Lara Khouzami, Hilda E. Ghadieh, Amjad Kanaan, Sami Azar, Frederic Harb
    Frontiers in Aging Neuroscience.2024;[Epub]     CrossRef
  • Impaired Sonic Hedgehog Responsiveness of Induced Pluripotent Stem Cell-Derived Floor Plate Cells Carrying the LRRK2-I1371V Mutation Contributes to the Ontogenic Origin of Lower Dopaminergic Neuron Yield
    Chandrakanta Potdar, Soham Jagtap, Khushboo Singh, Ravi Yadav, Pramod Kumar Pal, Indrani Datta
    Stem Cells and Development.2024;[Epub]     CrossRef
  • Dual-probe sandwich for Lewy body detection on nano-composite modified dielectric surface to determine Parkinson's disease
    Xi Zhang, Menghai Wu, Subash C.B. Gopinath, Yeng Chen
    Sensing and Bio-Sensing Research.2023; 42: 100599.     CrossRef
  • Neuroprotective effect of YIAEDAER peptide against Parkinson’s disease like pathology in zebrafish
    Qingyu Ren, Xin Jiang, Shanshan Zhang, Xin Gao, Yam Nath Paudel, Pengyu Zhang, Rongchun Wang, Kechun Liu, Meng Jin
    Biomedicine & Pharmacotherapy.2022; 147: 112629.     CrossRef
  • Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson’s disease like pathology in Zebrafish
    Qingyu Ren, Xin Jiang, Yam Nath Paudel, Xin Gao, Daili Gao, Pengyu Zhang, Wenlong Sheng, Xueliang Shang, Kechun Liu, Xiujun Zhang, Meng Jin
    Journal of Ethnopharmacology.2022; 292: 115234.     CrossRef
  • The Polyunsaturated Fatty Acid EPA, but Not DHA, Enhances Neurotrophic Factor Expression through Epigenetic Mechanisms and Protects against Parkinsonian Neuronal Cell Death
    Maria Rachele Ceccarini, Veronica Ceccarelli, Michela Codini, Katia Fettucciari, Mario Calvitti, Samuela Cataldi, Elisabetta Albi, Alba Vecchini, Tommaso Beccari
    International Journal of Molecular Sciences.2022; 23(24): 16176.     CrossRef
  • Comprehensive Methylation Profile of CSF cf DNA Revealed Pathogenesis and Diagnostic Markers for Early-Onset Parkinson’s Disease
    Jie Meng, Fenglin Wang, Lei Ji, Yuhua Liang, Wei Nian, Lele Song, Aiqin Zhu
    Epigenomics.2021; 13(20): 1637.     CrossRef
  • Early Expression of Neuronal Dopaminergic Markers in a Parkinson’s Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs)
    Carmen Parra-Cid, Eduardo Orozco-Castillo, Julieta García-López, Elena Contreras-Figueroa, Laura E. Ramos-Languren, Clemente Ibarra, Alfonso Carreón-Rodríguez, Michael Aschner, Mina Königsberg, Abel Santamaría
    CNS & Neurological Disorders - Drug Targets .2020; 19(2): 148.     CrossRef
  • Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
    Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, Christina Piperi
    Brain Sciences.2020; 10(10): 713.     CrossRef
  • Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
    Ingrid González-Casacuberta, Diana Luz Juárez-Flores, Constanza Morén, Gloria Garrabou
    Frontiers in Neuroscience.2019;[Epub]     CrossRef
  • Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations
    Ingrid González-Casacuberta, Diana-Luz Juárez-Flores, Mario Ezquerra, Raquel Fucho, Marc Catalán-García, Mariona Guitart-Mampel, Ester Tobías, Carmen García-Ruiz, José Carlos Fernández-Checa, Eduard Tolosa, María-José Martí, Josep Maria Grau, Rubén Fernán
    Aging.2019; 11(11): 3750.     CrossRef
  • Implications of DNA Methylation in Parkinson’s Disease
    Ernesto Miranda-Morales, Karin Meier, Ada Sandoval-Carrillo, José Salas-Pacheco, Paola Vázquez-Cárdenas, Oscar Arias-Carrión
    Frontiers in Molecular Neuroscience.2017;[Epub]     CrossRef
  • Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn–Yahr Stage
    Chen Shi, Zheng Zheng, Qi Wang, Chaodong Wang, Dabao Zhang, Min Zhang, Piu Chan, Xiaomin Wang, Ornit Chiba-Falek
    PLOS ONE.2016; 11(6): e0155758.     CrossRef

JMD : Journal of Movement Disorders Twitter